Professor of Medicine
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
Sebastian Schneeweiss, MD, ScD, is a Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology in the Department of Medicine, Brigham and Women’s Hospital in Boston. He holds a secondary appointment in the Department of Epidemiology of the Harvard T.H. Chan School of Public Health
His research focuses on assessing the effectiveness and safety of biopharmaceuticals in clinical practice. He has developed and applied analytic methods to improve the accuracy of estimating causal treatment effects of new drugs using complex digital healthcare databases. His work is published in >500 articles and is used for regulatory and coverage decision making around the globe. He is funded by NIH, PCORI, Burroughs Wellcome Fund, and FDA where he is also a voting consultant. He is Principal Investigator of the FDA Sentinel Innovation Center and co-leads the RCT-DUPLICATE initiative and ENCORE to understand when and how real-world evidence studies can reach robust conclusions to support regulatory and HTA submissions.
He is Past President of the International Society for Pharmacoepidemiology and is a Fellow of the American College of Epidemiology, the American College of Clinical Pharmacology, and the International Society for Pharmacoepidemiology.